Janet Freeman-Daily
@jfreemandaily.bsky.social
Lung cancer patient and research advocate. Cofounder #LCSM Chat, The ROS1ders, IASLC STARS. Also writer, retired engineer, science geek. Temporarily between feline overseers. Blog at grayconnections.net.
I'll be speaking in a webinar about ROS1+ lung cancer on November 17. Registration is FREE and available here: floridasocietyofclinicaloncologyjune152017.growthzoneapp.com/ap/Events/Re...
Hope you can join us!
Hope you can join us!
November 11, 2025 at 7:47 PM
I'll be speaking in a webinar about ROS1+ lung cancer on November 17. Registration is FREE and available here: floridasocietyofclinicaloncologyjune152017.growthzoneapp.com/ap/Events/Re...
Hope you can join us!
Hope you can join us!
Thanks for the laugh, @joehaldeman.bsky.social . "Kyloren syndrome" for the win!
December 31, 2024 at 5:49 PM
Thanks for the laugh, @joehaldeman.bsky.social . "Kyloren syndrome" for the win!
Geeking out with fellow NTRAP research advocate @whyiresist-1.bsky.social at IMAT meeting--learning about and providing patient perspectives on technologies for molecular analysis (proteomics, microfluidics, microdissection, digital pathology, etc). Fascinating!
www.cancer.gov/about-nci/or...
www.cancer.gov/about-nci/or...
December 18, 2024 at 3:52 PM
Geeking out with fellow NTRAP research advocate @whyiresist-1.bsky.social at IMAT meeting--learning about and providing patient perspectives on technologies for molecular analysis (proteomics, microfluidics, microdissection, digital pathology, etc). Fascinating!
www.cancer.gov/about-nci/or...
www.cancer.gov/about-nci/or...
Why #lungcancer (the #1 cancer killer) needs more funding and research:
Only 2 of the 7 LC patient advocates in this 2018 photo are still alive (including me). While newer treatments like targeted therapy and immune checkpoint inhibitors are effective for some, they don't work for all. #LCSM
Only 2 of the 7 LC patient advocates in this 2018 photo are still alive (including me). While newer treatments like targeted therapy and immune checkpoint inhibitors are effective for some, they don't work for all. #LCSM
December 7, 2024 at 5:29 PM
Why #lungcancer (the #1 cancer killer) needs more funding and research:
Only 2 of the 7 LC patient advocates in this 2018 photo are still alive (including me). While newer treatments like targeted therapy and immune checkpoint inhibitors are effective for some, they don't work for all. #LCSM
Only 2 of the 7 LC patient advocates in this 2018 photo are still alive (including me). While newer treatments like targeted therapy and immune checkpoint inhibitors are effective for some, they don't work for all. #LCSM
Dr Scott Ramsey of Fred Hutch Cancer Center opens the conference.
November 15, 2024 at 4:33 PM
Dr Scott Ramsey of Fred Hutch Cancer Center opens the conference.
Today I'm at the HICOR Value in Cancer Care conference on the Seattle waterfront. We get a different set of groupies bere.
November 15, 2024 at 3:59 PM
Today I'm at the HICOR Value in Cancer Care conference on the Seattle waterfront. We get a different set of groupies bere.